Event Date/Time: Feb 22, 2006
End Date/Time: Feb 24, 2006
Scientific advances from the human genome and proteome projects have lead to a new generation of diagnostic products. The vast spectrum of innovative tools has defined a new generation of healthcare tools that will enable more effective prediction, diagnosis, characterization, monitoring, and treatment of diseases. The molecular diagnostics arena is rapidly changing how compounds are developed and marketed. Business issues around discovering, choosing, validating, and introducing biomarker products will be explored in an interactive format where networking and collaborating opportunities are built in. This is the key event in molecular diagnostics and serves as a compass for the industry leaders.
Who should attend: Directors of R & D, Senior Managers, Managers, Laboratory Directors, Senior Scientists, and Senior Researchers for diagnostic, biotech and pharmaceutical businesses.